Zebra Medical Vision raises $30m and unveils automated AI-based radiology chest X-Ray reader
Zebra Medical Vision, a machine and deep learning start-up, has raised $30 million (€25.47 million) in C round funding, bringing the total investment in the company to $50 million (€42.45 million). The company is also unveiling its Textray chest X-Ray research, which it claims is the most comprehensive AI research conducted on chest X-Rays to date, providing a glimpse into a future automated chest X-Ray analysis product being developed by the company.
This round of investment is led by aMoon Ventures with the participation of strategic healthcare investors Aurum, Johnson & Johnson Innovation JJDC Inc. and Intermountain Healthcare and leading global AI experts Fei Fei Lee and Richard Socher. These new investors are joining a list of top existing investors Khosla Ventures, NVIDIA, Marc Benioff, OurCrowd and Dolby Ventures who also participated in this C round.
Dr. Yair Schindel
The chest X-Ray AI analytics product was trained using nearly 2 million images to identify 40 different common clinical findings. The results of the study establish a new bar for AI research in medical imaging, demonstrating high rates of agreement between the algorithm and human radiologist experts. This publication continues Zebra’s mission to drive a higher standard of care across the radiology domain and collaborate with the medical community to improve patient care.
Zebra Medical Vision is a leader in the growing market of AI-based tools for radiology. The company has received the CE regulatory mark for seven of its products, as well as approvals in numerous countries across Latin America and Asia, and continues to build a strong pipeline of AI based products.
It’s most recent announcements were the CE approval of CT brain bleed and mammography lesion detection algorithms. On its path to build the world’s most comprehensive visual lab, the company’s current and future arsenal of AI algorithms is bundled into a unique $1 (€0.85) per scan offering to hospitals, in order to meet the company founders’ vision toward scalable, transparent and affordable care globally.
Elad Benjamin
“Medical experts worldwide are facing a critical challenge in handling overwhelming demand. We are excited to partner with the Zebra team, which is harnessing the power of data and machine learning to provide physicians and healthcare systems with tools to dramatically increase capacity, while improving patient care,” said Dr. Yair Schindel MD, managing partner at aMoon VC. “This investment aligns with our vision of backing scalable and sustainable innovations that will have a valuable impact on fundamental facets of global healthcare.”
“I am pleased to partner with Zebras’ distinguished panel of investors,” added Morris Kahn, founder and owner of Aurum Ventures. “I am a big believer in AI based healthcare solutions and Zebra’s technologies will play a major role in improving the capacity and quality of treatment for patients all over the world.”
“I’m extremely proud of our team here at Zebra, that is pushing to develop and release next generation AI products with the commitment to make them affordable to the global market,” said Elad Benjamin, co-founder and CEO of Zebra.
Comment on this article below or via Twitter @IoTGN